We sought to strengthen our findings through the aggregation of exome-sequencing data from multiple publicly available datasets, which both provided nominal evidence for the role of rare coding variation in elevated diabetes risk and support mounting evidence that PAX4 is not a monogenic diabetes gene11. This evidence concerns the gene PAX4 and diabetes mellitus.